Lin Jiun-Nong, Chen Hsuan-Ju, Lin Ming-Chia, Lai Chung-Hsu, Lin Hsi-Hsun, Yang Chih-Hui, Kao Chia-Hung
Prof. Chia-Hung Kao, MD, Graduate Institute of Clinical Medical Science and School of Medicine, China Medical University, Taichung, Taiwan, No. 2, Yuh-Der Road, Taichung 404, Taiwan, Tel.: +886 4 22052121, ext. 7412, Fax: +886 4 22336174, E-mail:
Thromb Haemost. 2016 Jan;115(1):176-83. doi: 10.1160/TH15-05-0381. Epub 2015 Sep 3.
The spleen is a crucial organ in humans. However, little is known about the association of venous thromboembolism (VTE) with splenic injury and splenectomy in trauma patients. The aim of this study was to determine the subsequent risk of VTE following splenic injury and splenectomy. A nationwide retrospective cohort study was conducted by analysing data from the National Health Insurance Research Database in Taiwan. We included 6,162 splenic injury patients (3,033 splenectomised and 3,129 nonsplenectomised patients) and 24,648 comparison patients who were selected by frequency match based on sex, age, and the index year during 2000-2006. All patients were followed until the occurrence of VTE, 31 December, 2011, death, or withdrawal from the insurance program. The age of patients with splenic injury was 41.93 ± 16.44 years. The incidence rates of VTE were 11.81, 8.46, and 5.21 per 10,000 person-years in the splenic injury patients with splenectomy, splenic injury patients without splenectomy, and comparison patients, respectively. Compared with the comparison cohort, splenic injury patients with splenectomy exhibited a 2.21-fold risk of VTE (95% confidence interval [CI], 1.43-3.43), whereas those without splenectomy exhibited a 1.71-fold risk of VTE (95% CI, 1.05-2.80). The overall incidence rate of VTE was 1.97-fold higher in the splenic injury cohort than the comparison cohort (95% CI, 1.38-2.81). Although splenectomy increased the risk of VTE 1.35-fold compared with no splenectomy, the difference was not statistically significant (95% CI, 0.74-2.45). These results may alert physicians and patients to the complications of splenic injury and splenectomy.
脾脏是人体中的一个重要器官。然而,关于创伤患者静脉血栓栓塞症(VTE)与脾损伤及脾切除术之间的关联,人们了解甚少。本研究的目的是确定脾损伤和脾切除术后VTE的后续风险。通过分析台湾国民健康保险研究数据库的数据,进行了一项全国性的回顾性队列研究。我们纳入了6162例脾损伤患者(3033例接受脾切除术,3129例未接受脾切除术)以及24648例对照患者,后者是根据2000年至2006年期间的性别、年龄和索引年份通过频率匹配选取的。所有患者均随访至2011年12月31日VTE发生、死亡或退出保险计划。脾损伤患者的年龄为41.93±16.44岁。接受脾切除术的脾损伤患者、未接受脾切除术的脾损伤患者和对照患者的VTE发病率分别为每10000人年11.81、8.46和5.21例。与对照队列相比,接受脾切除术的脾损伤患者发生VTE的风险高2.21倍(95%置信区间[CI],1.43 - 3.43),而未接受脾切除术的患者发生VTE的风险高1.71倍(95%CI,1.05 - 2.80)。脾损伤队列中VTE的总体发病率比对照队列高1.97倍(95%CI,1.38 - 2.81)。尽管与未进行脾切除术相比,脾切除术使VTE风险增加了1.35倍,但差异无统计学意义(95%CI,0.74 - 2.45)。这些结果可能会提醒医生和患者注意脾损伤和脾切除术的并发症。